A mage accidentally drifts to Blue Star. The intelligent life on Blue Star cannot influence reality by manipulating dark matter, thus the mage loses their casting ability.
In order to recover...
Deep Blue Storage also has a 50% Russian stake.
In the global arena of public opinion, Russian media are far more effective than American media.
China's official statements are basically based on facts.
Meanwhile, Russian media outlets are producing science popularization videos, pointing out the technical principles of biological storage and how Amerika technology is similar to their own.
This again connects this incident with other issues, illustrating America's double standards.
Chinese bloggers who make a living by exploiting patriotic online traffic have been raking in the profits lately.
They beat the blogger who claimed to have "eaten 500,000" so badly he was completely disoriented.
America was outraged, stating that everyone had purchased the technology, so how could the two of you claim it as your own just because you bought it first?
The Europa League chimed in: "Yeah, yeah, if you two do this, won't I be unable to use what I buy?"
China and Russia retorted: "Who let us buy first? We registered the patent. We did this within the rules you set, and it conforms to the definition of an international patent."
America stated: Magic is a completely new thing and cannot be governed by old rules. If that's the case, then once we've acquired bio-computer technology, you won't be able to play anymore.
In fact, neither China nor Russia expected to gain any benefits from America; their original intention was simply to retaliate through public opinion.
Official negotiations use much more subtle language; the above only outlines the general meaning.
China and Russia felt that the other side's argument made sense, so the countries that currently own Magi sat down together to negotiate supplementary measures for intellectual property rights.
Of course, this method is currently kept secret.
This matter was discussed in the media for almost a month, and then inexplicably disappeared.
The world is never short of hot topics, and new hot topics are always emerging.
The Europa League said it was a real shame that you guys didn't even fight back.
They originally wanted to fan the flames, hoping to see the two sides clash, and ideally, that China would not back down an inch.
In that case, the value of biological storage technology would be greatly reduced, and it might be possible to buy it from America for a small amount of money.
They insisted on participating in bilateral negotiations in order to muddy the waters and see if they could take advantage of the situation.
Both sides maintained a basic level of rationality, which disappointed the Europa League.
Time flies, and by the end of 2024, the shipment volume of brain-computer interface VR has exceeded 30 million.
In its first year, Kechuang Future's sales exceeded 300 billion yuan, a figure that even the most optimistic people did not expect.
Kechuang Bio's market capitalization has exceeded one trillion US dollars, surpassing Moutai to become the largest listed company in China by market capitalization.
How should we evaluate the fact that the market value of Kechuang Bio has exceeded one trillion US dollars? Is the valuation of one trillion US dollars too high for Kechuang Bio? Intel's valuation is only around three hundred billion US dollars.
"Thanks for the invitation. Intel's valuation of 300 billion is because it has to compete with AMD and invests heavily in R&D every year."
However, Kechuang Bio has no competitors in its field; there are no rivals in the field of brain-computer interfaces.
In the field of lithium batteries, Japan's Panasonic has publicly declared its intention to defeat Kechuang Bio in the lithium battery sector.
News about battery research and development is coming in all sorts of times, but have you seen any products actually made to market? The so-called super battery with eight times the capacity of current batteries is still in the laboratory.
Even in the field of endorphins, the industrial preparation method developed by Zheng Li five years ago is still being used.
Foreign manufacturers have long sought to optimize or find alternative synthetic routes to circumvent Kechuang Bio's patents. However, they have found that they cannot bypass the key steps involved.
It's impossible to optimize it; it seems the current preparation route is already the optimal one.
According to my colleague at Kechuang Bio, there was a research and development team within Kechuang Bio that had been working on optimizing the preparation method of endorphins for five years without any results.
The entire team was split up and reassigned to other research groups. Even Kechuang Bio itself was no longer able to optimize the production process of endorphins.
I have to say Zheng Li is really amazing, it's like he has a third eye.
Invest in Kechuang Biotechnology; Kechuang Biotechnology essentially holds a monopoly. If Intel could also have a monopoly, it wouldn't be at its current price.
Not to mention that at Zheng Li's age, there's no need to worry about Kechuang Bio lacking the driving force for innovation for the next thirty years.
Furthermore, there is another point: China has too few companies with truly cutting-edge technologies.
Chinese companies with even a little bit of cutting-edge technology can enjoy a very high premium.
"The investment logic for investing in science and technology innovation and investing in Intel are completely different."
Intel's room for technological advancement is already very limited, and it also faces competition from other companies in the industry.
As manufacturing processes reached 14nm, Moore's Law gradually became ineffective. It became impossible to achieve the same level of technological progress every year as before.
And I don’t know if people remember now, but Intel used to only do chip design, and chip manufacturing was outsourced to foundries like TSMC.
However, starting in 2021, Intel restarted its chip foundry business, an area that requires massive investment.
Previously, we relied on rapid technological iteration to only capture the high-end of the industry chain. Now that technology can no longer iterate so quickly, we're starting to earn money through hard work.
Earning money is not shameful, but when you participate in the competition for chip manufacturing, you can no longer enjoy high premiums.
Because the chip foundry industry is a high-investment, high-return field, the returns must be continuously invested in equipment upgrades and technology research and development.
My dear reader, there's more to this chapter! Please click the next page to continue reading—even more exciting content awaits!